FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205025077> ?p ?o ?g. }

• W3205025077 endingPage "109997" @default.
• W3205025077 startingPage "109997" @default.
• W3205025077 abstract "PurposeTo determine chest CT changes 6 months and 12 months after the onset of coronavirus disease 2019 (COVID-19) in patients with diabetes or hyperglycemia and the risk factors for these residual lung abnormalities.MethodsIn total, 141 COVID-19 patients were assigned to group 1 (diabetes), group 2 (secondary hyperglycemia) or group 3 (controls). Initial and six- and twelve-month follow-up computed tomography (CT) scans were performed 16 days, 175 days and 351 days after symptom onset, respectively. CT findings and clinical and peak laboratory parameters were collected and compared. Univariable and multivariable logistic regression analyses were performed to identify the independent predictors for the presence of residual lung abnormalities at the 6-month follow-up exam. Seven variables (age; the presence of acute respiratory distress syndrome; the duration of hospitalization; the peak levels of lactate dehydrogenase (LDH) and C-reactive protein; and the initial total CT score) were chosen in the final multivariable models.ResultsAt the six-month follow-up, abnormalities were still observed on chest CT in 77/141 (54.6%) patients. Reticular patterns (40/141, 28.4%) and ground-glass opacities (GGOs) (29/141, 20.6%) were the most common CT abnormalities on the follow-up CT scans. Patients in Groups 1 and 2 had significantly higher incidences of residual lung abnormalities than those in Group 3 (65.4% and 58.3%, respectively vs. 36.6%; p < 0.05). Twelve months after disease onset, the chest CT changes persisted in 13/25 (52.0%) patients. A duration of hospitalization > 20 days (OR: 5.630, 95% CI: 1.394–22.744, p = 0.015), an LDH level ≥ 317 U/L (OR: 7.020, 95% CI: 1.032–47.743, p = 0.046) and a total CT score > 15 (OR: 9.919, 95% CI: 1.378–71.415, p = 0.023) were independent predictors of residual pulmonary abnormalities in patients with diabetes or secondary hyperglycemia.ConclusionsA considerable proportion of surviving COVID-19 patients with diabetes or secondary hyperglycemia had residual pulmonary abnormalities six months after disease onset, and we found evidence of persistent chest CT changes at the one-year follow-up. Residual lung abnormalities were associated with longer hospital stays, higher peak LDH levels and higher initial total CT scores." @default.
• W3205025077 created "2021-10-25" @default.
• W3205025077 creator A5009017779 @default.
• W3205025077 creator A5010386822 @default.
• W3205025077 creator A5013116619 @default.
• W3205025077 creator A5015401166 @default.
• W3205025077 creator A5029848730 @default.
• W3205025077 creator A5032087142 @default.
• W3205025077 creator A5037178585 @default.
• W3205025077 creator A5037289000 @default.
• W3205025077 creator A5039981075 @default.
• W3205025077 creator A5050166540 @default.
• W3205025077 creator A5057117256 @default.
• W3205025077 creator A5083715162 @default.
• W3205025077 creator A5090614836 @default.
• W3205025077 date "2021-11-01" @default.
• W3205025077 modified "2023-10-09" @default.
• W3205025077 title "Follow-up study of pulmonary sequelae in discharged COVID-19 patients with diabetes or secondary hyperglycemia" @default.
• W3205025077 cites W1803784511 @default.
• W3205025077 cites W1978190433 @default.
• W3205025077 cites W1978349722 @default.
• W3205025077 cites W1980321651 @default.
• W3205025077 cites W2005041300 @default.
• W3205025077 cites W2017898137 @default.
• W3205025077 cites W2029648873 @default.
• W3205025077 cites W2047173408 @default.
• W3205025077 cites W2057072852 @default.
• W3205025077 cites W2060808510 @default.
• W3205025077 cites W2091495292 @default.
• W3205025077 cites W2099475032 @default.
• W3205025077 cites W2124413369 @default.
• W3205025077 cites W2163264059 @default.
• W3205025077 cites W2620241325 @default.
• W3205025077 cites W2758783533 @default.
• W3205025077 cites W2974984390 @default.
• W3205025077 cites W3001118548 @default.
• W3205025077 cites W3003217347 @default.
• W3205025077 cites W3008028633 @default.
• W3205025077 cites W3008090866 @default.
• W3205025077 cites W3011048075 @default.
• W3205025077 cites W3024432354 @default.
• W3205025077 cites W3024925768 @default.
• W3205025077 cites W3026032531 @default.
• W3205025077 cites W3040075864 @default.
• W3205025077 cites W3040193044 @default.
• W3205025077 cites W3040818588 @default.
• W3205025077 cites W3042557581 @default.
• W3205025077 cites W3043552652 @default.
• W3205025077 cites W3091355259 @default.
• W3205025077 cites W3112783420 @default.
• W3205025077 cites W3120387768 @default.
• W3205025077 cites W4206245015 @default.
• W3205025077 cites W4240986128 @default.
• W3205025077 doi "https://doi.org/10.1016/j.ejrad.2021.109997" @default.
• W3205025077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8500791" @default.
• W3205025077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34634534" @default.
• W3205025077 hasPublicationYear "2021" @default.
• W3205025077 type Work @default.
• W3205025077 sameAs 3205025077 @default.
• W3205025077 citedByCount "8" @default.
• W3205025077 countsByYear W32050250772022 @default.
• W3205025077 countsByYear W32050250772023 @default.
• W3205025077 crossrefType "journal-article" @default.
• W3205025077 hasAuthorship W3205025077A5009017779 @default.
• W3205025077 hasAuthorship W3205025077A5010386822 @default.
• W3205025077 hasAuthorship W3205025077A5013116619 @default.
• W3205025077 hasAuthorship W3205025077A5015401166 @default.
• W3205025077 hasAuthorship W3205025077A5029848730 @default.
• W3205025077 hasAuthorship W3205025077A5032087142 @default.
• W3205025077 hasAuthorship W3205025077A5037178585 @default.
• W3205025077 hasAuthorship W3205025077A5037289000 @default.
• W3205025077 hasAuthorship W3205025077A5039981075 @default.
• W3205025077 hasAuthorship W3205025077A5050166540 @default.
• W3205025077 hasAuthorship W3205025077A5057117256 @default.
• W3205025077 hasAuthorship W3205025077A5083715162 @default.
• W3205025077 hasAuthorship W3205025077A5090614836 @default.
• W3205025077 hasBestOaLocation W32050250771 @default.
• W3205025077 hasConcept C126322002 @default.
• W3205025077 hasConcept C134018914 @default.
• W3205025077 hasConcept C141071460 @default.
• W3205025077 hasConcept C151956035 @default.
• W3205025077 hasConcept C2776178081 @default.
• W3205025077 hasConcept C2777714996 @default.
• W3205025077 hasConcept C555293320 @default.
• W3205025077 hasConcept C71924100 @default.
• W3205025077 hasConcept C90924648 @default.
• W3205025077 hasConceptScore W3205025077C126322002 @default.
• W3205025077 hasConceptScore W3205025077C134018914 @default.
• W3205025077 hasConceptScore W3205025077C141071460 @default.
• W3205025077 hasConceptScore W3205025077C151956035 @default.
• W3205025077 hasConceptScore W3205025077C2776178081 @default.
• W3205025077 hasConceptScore W3205025077C2777714996 @default.
• W3205025077 hasConceptScore W3205025077C555293320 @default.
• W3205025077 hasConceptScore W3205025077C71924100 @default.
• W3205025077 hasConceptScore W3205025077C90924648 @default.
• W3205025077 hasLocation W32050250771 @default.
• W3205025077 hasLocation W32050250772 @default.
• W3205025077 hasLocation W32050250773 @default.

• next